Publications
Original Article
T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity
Cancer Vaccines
2013
Authors:
Cecil DL, Park KH, Gad E, Childs JS, Higgins DM, Plymate SR, Disis ML
Journal:
Breast Cancer Research and Treatment
Volume:
139(3)
Page:
657-65
Original Article
A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease
Cancer Vaccines
2013
Authors:
Disis, M.L., Gad, E. Herendeen, D.R., Lai, V.P., Park, K.H., Cecil, D.L., O’Meara, M.M., Treuting, P.M., and Lubet, R.A.
Journal:
Cancer Prevention Research
Volume:
6(12)
Page:
1273-82
Review Article
Therapeutic vaccines for ovarian cancer
Cancer Vaccines
2013
Authors:
Liao JB, Disis ML.
Journal:
Gynecologic Oncology
Volume:
130(3)
Page:
667-73
Original Article
Identification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions
Cancer Vaccines
2013
Authors:
Broussard, E.K., Kim, R., Wiley, J.C., Pritchard, D., Marquez, J.P., Annis, J.E., and Disis, M.L.
Journal:
Cancer Prevention Research
Volume:
6(7)
Page:
666-74
Original Article
Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs
Cancer Vaccines
2012
Authors:
Kievit, FM, Stephen, ZR, Veiseh, O, Arami, H, Wang, T, Lai, VP, Park, JO, Ellenbogen, RG, Disis, ML, and Zhang, M
Journal:
ACS Nano
Volume:
6(3)
Page:
2591-601
Original Article
The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer
Cancer Vaccines
2011
Authors:
Hahn T., Bradley-Dunlop D. J., Hurley L. H., Von-Hoff D., Gately S., Disis M. L., Lu H. L., Penichet M. L., Besselsen D. G., Cole B. B., Meeuwsen T., Walker E., Akporiaye E. T.
Journal:
BMC Cancer
Volume:
11
Page:
471
Review Article
Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of concept
Cancer Vaccines
2011
Authors:
0'Meara M., Disis M.L.
Journal:
OMICS
Volume:
15(9)
Page:
579-88
Review Article
The ultimate in cancer chemoprevention: cancer vaccines
Cancer Vaccines
2010
Authors:
Disis ML.
Journal:
Cancer Prevention Research
Volume:
3(4)
Page:
406=9
Original Article
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen
Cancer Vaccines
2010
Authors:
Karyampudi L, Krco CJ, Kalli KR, Erskine CL, Hartmann LC, Goodman K, Ingle JN, Maurer MJ, Nassar A, Yu C, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, and Knutson KL
Journal:
Cancer Immunology, Immunotherapy
Volume:
59(1)
Page:
161-71
Original Article
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
Cancer Vaccines
2010
Authors:
Olson B. M., Frye T. P., Johnson L. E., Fong L., Knutson K. L., Disis M. L., McNeel D. G.
Journal:
Cancer Immunology Immunotherapy
Volume:
59(6)
Page:
943-53